Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/12/2008 | CN101301416A Decoction for treating chincough |
11/12/2008 | CN101301414A Chinese medicine for treating pelvic inflammation and preparation |
11/12/2008 | CN101301396A Medicament for treating oral ulcer of children and preparation thereof |
11/12/2008 | CN101301391A Chinese herbal medicine oral liquid cold tea formulation for treating damp-heat viral hepatitis b |
11/12/2008 | CN101301388A Chinese medicine film-forming products suitable for mammilla of milk cattle |
11/12/2008 | CN101301382A Externally used Chinese medicine for treating viral hepatitis jaundice and preparation thereof |
11/12/2008 | CN101301365A Chinese and western compound medicament composition for treating bacterial enteritis of aquatic livestock |
11/12/2008 | CN101301342A Soaking medicament for treating hyperkeratotic tinea manuum and tinea pedis |
11/12/2008 | CN101301315A Uses of black-tail snake in preparing bait for treating lymphocyst of flatfish |
11/12/2008 | CN101301312A Beriberi medicament and preparation thereof |
11/12/2008 | CN101301301A Uses of rutin and quercetin-7-rhamnose in preparing anti-hepatitis medicament |
11/12/2008 | CN101301299A Medicament composition and use thereof in preparing antimicrobial medicament |
11/12/2008 | CN101301296A Compound preparation for treating beriberi and production method |
11/12/2008 | CN101301291A Compound enrofloxacin injection for animals and preparation thereof |
11/12/2008 | CN101301289A Uses of berberine and analog thereof in pump for reversing multidrug resistance |
11/12/2008 | CN101301287A Use of composition of isoflavonoids from Belamcanda chinensis in preparing anti-hepatitis medicament |
11/12/2008 | CN101301278A Clindamycin phosphate freeze-dried powder needle and preparation thereof |
11/12/2008 | CN101301274A Compound mequindox soluble powder for animals and preparation thereof |
11/12/2008 | CN101301272A Sustained-release agent containing mezlocillin and uses thereof |
11/12/2008 | CN101301271A Sustained-release agent containing penicillins antibiotics and uses thereof |
11/12/2008 | CN101301270A Sustained-release agent containing antibiotic and uses thereof |
11/12/2008 | CN101301269A Sustained-release agent containing sulbenicillin and uses thereof |
11/12/2008 | CN101301268A Composition of doxycycline hydrochloride injection for animals and preparation technique thereof |
11/12/2008 | CN101301263A Sustained-release agent containing flucloxacillin and uses thereof |
11/12/2008 | CN101301262A Sustained-release agent containing ampicillin and use thereof |
11/12/2008 | CN101301261A Sustained-release agent containing TIC and use thereof |
11/12/2008 | CN101301260A Sustained-release agent containing carbenicillin and use thereof |
11/12/2008 | CN101301083A Ginger tea capable of preventing and treating common cold |
11/12/2008 | CN101301028A Chinese herbal medicine feed additive |
11/12/2008 | CN100432212C Grifola frondosa strain, culture method and application thereof |
11/12/2008 | CN100432107C Protein for promoting erythrocyte growth factor activity and its use |
11/12/2008 | CN100432098C Antigen epitope I of B cell of chicken IBDV VP3 protein |
11/12/2008 | CN100432070C Novel sulfamides and their use as endothelin receptor antagonists |
11/12/2008 | CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same |
11/12/2008 | CN100432055C Tricyclic protein kinase inhibitors |
11/12/2008 | CN100432049C Cycloalkene derivatives, process for producing the same and use |
11/12/2008 | CN100432047C Synthesis process of peramivir as medicine for antagonizing influenza and bird flu virus |
11/12/2008 | CN100432037C Bromo-2, 4'-dihydroxy diphenyl ether compound and its synthesizing method |
11/12/2008 | CN100431612C Hepatitis B nucleic acid vaccine, its preparation method and application |
11/12/2008 | CN100431604C C1 inhibitor with short half-life for transient treatment |
11/12/2008 | CN100431564C Chinese medicine composition for preventing avian flu |
11/12/2008 | CN100431561C Preparing method and product of mile swertia herb dripping pill |
11/12/2008 | CN100431559C Medicine for treating common cold and its preparing method |
11/12/2008 | CN100431558C Chinese herbal medicine capsule for curing tuberculosis and its preparing method |
11/12/2008 | CN100431549C Nanometer dental caries prevention and antibiotic material, and its prepn. method and toothpaste containing the material |
11/12/2008 | CN100431542C Application of yohimbine and berberine mixture in medicament preparation |
11/12/2008 | CN100431525C Production method of liposome suspended liquid and products thereof |
11/12/2008 | CN100431419C Biological agent for foot disinfection |
11/11/2008 | US7449575 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection |
11/11/2008 | US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
11/11/2008 | US7449556 genetic engineered antibody fragment having preferential binding for RNA virus epitopes, with variable light or heavy chain domains;immunology; veternary medicine |
11/11/2008 | US7449545 Antimicrobial bolisin peptides |
11/11/2008 | US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis |
11/11/2008 | US7449492 Therapeutic agents—I |
11/11/2008 | US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones |
11/11/2008 | US7449479 Hepatitis C virus inhibitors |
11/11/2008 | US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
11/11/2008 | US7449446 Synergistic mixture; anticoagulants |
11/11/2008 | US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus) |
11/11/2008 | US7449310 For conferring protective immunity against F. necrophorum |
11/11/2008 | US7449301 Pharmaceutical composition and method for activating macrophage using the same |
11/11/2008 | US7449190 Assays for assembly of Ebola virus nucleocapsids |
11/11/2008 | US7449189 Glycoconjugate vaccines for use in immune-compromised populations |
11/11/2008 | US7449178 Attenuated gram negative bacteria |
11/11/2008 | US7449175 Delivery of erectile dysfunction drugs through an inhalation route |
11/11/2008 | US7449174 Delivery of analgesics through an inhalation route |
11/11/2008 | US7449172 Delivery of antiemetics through an inhalation route |
11/06/2008 | WO2008134694A1 N-halogenated amino acid formulations and methods for cleaning and disinfection |
11/06/2008 | WO2008134687A1 N-halogenated amino acid formulations |
11/06/2008 | WO2008134659A2 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
11/06/2008 | WO2008134450A2 Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115 |
11/06/2008 | WO2008134036A1 ALPHA-SUBSTITUTED ARYLMETHYL PIPERAZINE PYRAZOLO[1,5-α]PYRIMIDINE AMIDE DERIVATIVES |
11/06/2008 | WO2008134035A1 Alpha-unsubstituted arylmethyl piperazine pyrazolo[1,5-a] pyrimidine amide derivatives |
11/06/2008 | WO2008133709A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
11/06/2008 | WO2008133684A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
11/06/2008 | WO2008133669A2 Viral inhibitors |
11/06/2008 | WO2008133595A1 Compositions and methods for stimulating an immune response in-vivo and in-vitro |
11/06/2008 | WO2008133192A1 Fused imidazole compound and use thereof |
11/06/2008 | WO2008133098A1 Eradicating agent for helicobacter pylori |
11/06/2008 | WO2008132709A1 Products for altering il-33 activity and methods therefor |
11/06/2008 | WO2008132524A1 Novel apiary composition |
11/06/2008 | WO2008132152A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
11/06/2008 | WO2008132134A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
11/06/2008 | WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives |
11/06/2008 | WO2008131635A1 Acyclic nucleoside phosphonate derivatives and their medical use |
11/06/2008 | WO2008131502A2 Antiviral compounds of the adamantane type |
11/06/2008 | WO2008131491A1 Treatment of virally induced lesions |
11/06/2008 | WO2008131481A1 Treatment of mesangioproliferative diseases |
11/06/2008 | WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists |
11/06/2008 | WO2008099068A3 Liquid anhydrous composition to be incorporated into the drinking water of cattle |
11/06/2008 | WO2008096081A3 Use of riluzole and derivatives thereof for producing new drugs |
11/06/2008 | WO2008070358A3 N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain |
11/06/2008 | WO2008048340A3 Cationic steroid antimicrobial compositions for treating poxvirus infections |
11/06/2008 | WO2008024977A3 Isoquinoline, quinazoline and phthalazine derivatives |
11/06/2008 | WO2007144057A3 Antimicrobial carbon |
11/06/2008 | WO2007120556A3 Antiviral methods |
11/06/2008 | WO2007053724A3 Crystalline forms of cefdinir potassium salt |
11/06/2008 | US20080275214 Viral peptides for use in activating immune response to treat and prevent viral infection |
11/06/2008 | US20080275126 Aliphatic acid-containing n-halogenated amino acid formulations |
11/06/2008 | US20080275109 Drug, food or drink product containing proanthocyanidine derived from hop, hop bract or apple; prevents digestive diseases caused by Helicobacter pylori; freeze drying |